The largest database of trusted experimental protocols

3 protocols using cd16 32 percpcy5

1

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
A panel of monoclonal antibodies was developed to enable phenotypic characterization of B and T lymphocyte subpopulations: CD3-FITC, CD4-APC, CD25-BV421, FoxP3-PE, CD19-PeCy7, CD9-BB700 (BD Bioscience, France), CD24-BV510, and CD38-APC-Cy7 (Sony Biotechnology, UK); hematopoietic stem and progenitor cells: CD34-BV421 (Biolegend, France), cKit-APC-H7, CD135-PE, lineage-FITC, Sca-1-BV510, CD16/32-PerCPCy5.5, CD127-APC (BD Bioscience), and TLR-4-PeCy7 (Biolegend); and dendritic cells: CD11c-PeCy7 (eBioscience, France), CMH-II-FITC, Siglec-H-BV510, CD11b-APC-H7, and CD103-PerCP5. For intracellular staining, cells were fixed and permeabilized using a Cytofix/Cytoperm kit (BD Biosciences). For in vitro human B cell differentiation experiments, cells were stained with Fixable Viability Dye eFluor 450 to identify dead cells, followed by staining with CD25-BV605 (Biolegend), CD19-BUV395, CD9-FITC, CD27-BUV737, CD38-BV711 and intracellular IL-10-PE (BD Bioscience). Cells were analyzed on a Canto II flow cytometer (BD Biosciences). Data were acquired using Diva 8.0 software and analyzed with FlowJo X (TreeStar, Williamson Way, Ashland, USA). Fluorescence minus one staining controls were used for all panels, and dead cells were removed using viability staining.
+ Open protocol
+ Expand
2

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood, spleens, and mesenteric lymph nodes (mLN) were collected 24 h after CLP surgery or sham surgery to obtain single cells for flow cytometry. Cells were stained for 30 min at 4°C with the following antibodies: CD45-Percp, CD3-FITC, CD4-Percp, CD8-APC, B220-PE, CD11c-APC, CD11b-FITC, F4/80-PE, and Ly6G-PE. Following incubation, red blood cells were lysed and washed 3 times with a FACS buffer before collecting data. Immunophenotyping analysis of the BMDMs was conducted using a flow cytometry technique. Briefly, 100 μl of cell suspension was incubated for 5 min with 5 μl of Fc blocker (Innovex, USA). Then, 1 μl of monoclonal antibodies (CD11b-FITC, F4/80-PE, F4/80-FITC, MHCII-FITC, CD80-PE, CD80-APC, CD16/32-Percp-cy5.5, and CD64-APC, BD, USA) were added and incubated at 4°C for 30 min and washed 3 times with the FACS buffer. All samples were analyzed using a FACSCalibur flow cytometer (BD, USA).
+ Open protocol
+ Expand
3

Bone Marrow Cell Isolation and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Thawed bone marrow was resuspended in 1mL RBC lysis buffer and incubated for 1 minute at 25°C. PBS (25mL, Gibco) was added to suspension and centrifuged prior to resuspension in thawing medium.
Five million cells were plated on a round-bottom 96-well plate. Samples were centrifuged at 400 rcf for 5 minutes and incubated for 20 minutes in 30uL 0.2μg/uL (6μg) of CD16/32 PerCP-Cy5.5 (BD Biosciences, USA). Samples were washed and then incubated in 30μL of a 6-colour panel and Ms CD16/32 FACS Block (see Table S1). The gating strategy is shown in Figure 5A. Single-colour compensation controls were either prepared using remaining bone marrow (500,000 cells/well) or using rat/hamster compensation beads (BD anti-rat, anti-hamster Ig κ/negative control set, BD Biosciences).
Both compensation controls and samples were washed twice with 200μL FACS buffer (2% FCS (Gibco) in PBS (Gibco)), then resuspended in 200μL FACS buffer and transferred to 5mL FACS tubes for analysis on a BD FACSAria Fusion (SORP) at the Translational Research Institute (Brisbane, Australia). Percentages of hematopoietic stem cells (HSPCs), common myeloid progenitors (CMPs) and granulocyte-macrophage progenitors (GMPs) were quantified (Figure 5A).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!